Molecular basis for the action of Au(I) drugs in rheumatoid arthritis.

14
Molecular basis for the action of Au(I) drugs in rheumatoid arthritis

Transcript of Molecular basis for the action of Au(I) drugs in rheumatoid arthritis.

Page 1: Molecular basis for the action of Au(I) drugs in rheumatoid arthritis.

Molecular basis for the action of Au(I)

drugs in rheumatoid arthritis

Page 2: Molecular basis for the action of Au(I) drugs in rheumatoid arthritis.

Rheumatoid arthritis

immune system attacks joints

chronic inflammatory disease

Wikipedia - Joint , Rheumatoid Arthritis

Page 3: Molecular basis for the action of Au(I) drugs in rheumatoid arthritis.

Anti-inflammatory and immunomodulatory effects of gold(I)-containing drugs

J. Biol. Chem., Vol. 276, Issue 36, 34074-34081, September 7, 2001

Collagenase

interleukin- 2 (IL-2)

proteins involved in promoting inflammation

Cytokines

interleukin-2 receptor

genes involved in promoting inflammation

down-regulated

Page 4: Molecular basis for the action of Au(I) drugs in rheumatoid arthritis.

Anti-inflammatory and immunomodulatory effects of gold(I)-containing drugs

J. Biol. Chem., Vol. 276, Issue 36, 34074-34081, September 7, 2001

antioxidative stress proteins

g - glutamylcysteine synthetase

antioxidative stress genes

induce

heme oxygenase

GO

Page 5: Molecular basis for the action of Au(I) drugs in rheumatoid arthritis.

Transcription factors

http://en.wikipedia.org/wiki/Transcription_factor

http://www.ndsu.edu/instruct/mcclean/plsc731/transcript/transcript1.htm

http://www.piercenet.com/Proteomics/browse.cfm?fldID=843944B3-65F9-42A9-BF7A-6F91B4A6FBBB

facilitate or inhibit gene expression

Regulatory Region Gene

Transcription

DNA

c-Jun c-FosRNA

Polymerase II

AP-1 transcription factor

TGACTCA

Page 6: Molecular basis for the action of Au(I) drugs in rheumatoid arthritis.

Gold(I)-drugs inhibit AP-1

Page 7: Molecular basis for the action of Au(I) drugs in rheumatoid arthritis.

Electrophoresis

EMSA

Electrophoretic Mobility Shift Assay

Lane 1 is a negative control, and contains only DNA. Lane 2 contains protein as well as a DNA fragment that, based on its sequence, does not interact. Lane 3 contains protein and a DNA fragment that does react; the resulting complex is larger, heavier, and slower-moving.

Gel Electrophoresis

Page 8: Molecular basis for the action of Au(I) drugs in rheumatoid arthritis.

Gold(I)-drugs inhibit AP-1 binding to DNA

Proc. Natl. Acad. Sci. USA Vol. 92, pp. 4497-4501, May 1995

Page 9: Molecular basis for the action of Au(I) drugs in rheumatoid arthritis.

Effect of Gold(I)-drugs on other transcription factors

Proc. Natl. Acad. Sci. USA Vol. 92, pp. 4497-4501, May 1995

Page 10: Molecular basis for the action of Au(I) drugs in rheumatoid arthritis.

Gold(I) inhibition of transcription in vivo

Regulatory Region Gene for CAT

Transcription

DNA

c-Jun c-FosRNA

Polymerase II

AP-1 transcription factor

TGACTCA

(CAT) chloramphenicol acetyltransferasereporter gene

Page 11: Molecular basis for the action of Au(I) drugs in rheumatoid arthritis.

Interaction of Cys residues on Jun and Fos with Au(I)

Proc. Natl. Acad. Sci. USA Vol. 92, pp. 4497-4501, May 1995

~CH2SH ~CH2OH

Page 12: Molecular basis for the action of Au(I) drugs in rheumatoid arthritis.

AP-1 : DNA interaction

Nature vol. 373, pp.257-261, 1995

Page 13: Molecular basis for the action of Au(I) drugs in rheumatoid arthritis.

AP-1 : DNA interaction

Nature vol. 373, pp.257-261, 1995

Page 14: Molecular basis for the action of Au(I) drugs in rheumatoid arthritis.

AP-1 : DNA interaction

Nature vol. 373, pp.257-261, 1995